drugset / Trial / NCT00453908

Alfuzosin Versus Placebo in Acute Urinary Retention

NCT00453908

Phase 3 Terminated 160 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin compared to placebo, will increase the number of patients with satisfying spontaneous voiding after acute urinary retention treated with Clean Self-Catheterization. Furthermore is investigated the safety of the medical treatment and self-catheterization.

Timeline

Start
2004-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule